Cargando…
PTPN22 R620W Polymorphism is Associated with Myasthenia Gravis Risk: A Systematic Review and Meta-Analysis
BACKROUND: The association between PTPN22 R620W polymorphism and risk of myasthenia gravis (MG) remains controversial. Therefore, we did this meta-analysis to investigate this association. MATERIAL/METHODS: We did a comprehensive search in PubMed, Medline, Embase, CNKI (China National Knowledge Infr...
Autores principales: | Xiong, Xunbo, Xiang, Mingqing, Cheng, Xianglin, Huang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559008/ https://www.ncbi.nlm.nih.gov/pubmed/26318187 http://dx.doi.org/10.12659/MSM.894307 |
Ejemplares similares
-
The Association of PTPN22 R620W Polymorphism Is Stronger with Late-Onset AChR-Myasthenia Gravis in Turkey
por: Kaya, Gizem A., et al.
Publicado: (2014) -
The Protein Tyrosine Phosphatase Nonreceptor 22 (PTPN22) R620W Functional Polymorphism in Psoriasis
por: Bin Huraib, Ghaleb, et al.
Publicado: (2018) -
Immunosuppressive and monoclonal antibody treatment for myasthenia gravis: A network meta‐analysis
por: Wang, Liang, et al.
Publicado: (2019) -
Association Between Protein Tyrosine Phosphatase Non-Receptor Type 22 (PTPN22) Polymorphisms and Risk of Ankylosing Spondylitis: A Meta-analysis
por: Meng, Xiantao, et al.
Publicado: (2017) -
The PTPN22 C1858T (R620W) functional polymorphism in inflammatory bowel disease
por: Zaid, Younes, et al.
Publicado: (2018)